Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease

The primary aim of this study was to investigate adenosine receptors (ARs) in bronchoalveolar lavage (BAL) macrophages from patients with chronic obstructive pulmonary disease (COPD) and age‐matched healthy smokers. A2BARs were significantly decreased in BAL macrophages from patients with COPD when compared with healthy smokers. The effect of proinflammatory cytokines and oxidative/ nitrosative stress on AR expression and function in U937 cells before and after PMA treatment was evaluated. IL‐1 β and TNF‐α treatment up‐regulated A2A‐ and A3ARs but not A1‐ or A2BARs, whereas IL‐6 did not modify AR expression. In contrast, oxidative/nitrosative stress selectively decreased A2BAR expression, which was associated with a reduction in the potency of the adenosine agonist 5′‐N‐ethylcarboxamideadenosine (NECA) to induce cAMP. Further, the ability of NECA to enhance cell proliferation was increased after oxidative/nitrosative stress. The specific involvement of A2BARs was investigated by using potent and selective A2BAR antagonist and by A2BAR knockdown using siRNA and demonstrated responses similar to those obtained with oxidative/nitrosative stress. N‐acetylcysteine (NAC), an antioxidant agent, counteracted the decrease in A2BAR expression, as well as the altered NECA effects on cAMP and cell proliferation. These findings highlight the central role of A2BARs in alveolar macrophages, suggesting that their modulation could represent an innovative pharmacological strategy to manage COPD.—Varani, K., Caramori, G., Vincenzi, F., Tosi, A., Barczyk, A., Contoli, M., Casolari, P., Triggiani, M., Hansel, T., Leung, E., MacLennan, S., Barnes, P. J., Fan Chung, K., Adcock, I., Papi, A., Borea, P. A. Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. FASEB J. 24, 1192–1204 (2010). www.fasebj.org

[1]  D. J. Schneider,et al.  Adenosine signaling and the regulation of chronic lung disease. , 2009, Pharmacology & therapeutics.

[2]  Michael R. Blackburn,et al.  Enhanced Airway Inflammation and Remodeling in Adenosine Deaminase-Deficient Mice Lacking the A2B Adenosine Receptor1 , 2009, The Journal of Immunology.

[3]  Hongwei Yao,et al.  Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke. , 2009, American journal of respiratory cell and molecular biology.

[4]  S. Hodge,et al.  Chemotactic Mediators of Th1 T-cell Trafficking in Smokers and COPD Patients , 2009, COPD.

[5]  D. Rees,et al.  The adenosine a2b receptor: its role in inflammation. , 2008, Endocrine, metabolic & immune disorders drug targets.

[6]  S. Srinivasan,et al.  Blockade of adenosine A2B receptors ameliorates murine colitis , 2008, British journal of pharmacology.

[7]  I. Morita,et al.  Protein kinase CK2 is a key activator of histone deacetylase in hypoxia‐associated tumors , 2008, International journal of cancer.

[8]  M. Andrades,et al.  Oxidative stress in chronic obstructive pulmonary disease patients submitted to a rehabilitation program. , 2007, Respiratory medicine.

[9]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[10]  I. Adcock,et al.  IL-1β and TNF-α Regulation of the Adenosine Receptor (A2A) Expression: Differential Requirement for NF-κB Binding to the Proximal Promoter1 , 2006, The Journal of Immunology.

[11]  Hongyan Zhong,et al.  Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. , 2006, The Journal of clinical investigation.

[12]  I. Adcock,et al.  Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[13]  H. Schünemann,et al.  Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD , 2006, European Journal of Clinical Nutrition.

[14]  I. Adcock,et al.  IL-1 beta and TNF-alpha regulation of the adenosine receptor (A2A) expression: differential requirement for NF-kappa B binding to the proximal promoter. , 2006, Journal of immunology.

[15]  K. Fan Chung Phosphodiesterase inhibitors in airways disease. , 2006, European journal of pharmacology.

[16]  I. Adcock,et al.  Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. , 2006, The Journal of allergy and clinical immunology.

[17]  P. Barnes Emerging targets for COPD therapy. , 2005, Current drug targets. Inflammation and allergy.

[18]  K. Klotz,et al.  Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors. , 2005, Biochemical pharmacology.

[19]  E. Bateman,et al.  Roflumilast—an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial , 2005, The Lancet.

[20]  K. Klotz,et al.  Expression, Pharmacological Profile, and Functional Coupling of A2B Receptors in a Recombinant System and in Peripheral Blood Cells Using a Novel Selective Antagonist Radioligand, [3H]MRE 2029-F20 , 2005, Molecular Pharmacology.

[21]  N. Papadopoulos,et al.  Oxidants in asthma and in chronic obstructive pulmonary disease (COPD). , 2005, Current pharmaceutical design.

[22]  K. Varani,et al.  A3 Adenosine Receptor Activation Inhibits Cell Proliferation via Phosphatidylinositol 3-Kinase/Akt-dependent Inhibition of the Extracellular Signal-regulated Kinase 1/2 Phosphorylation in A375 Human Melanoma Cells* , 2005, Journal of Biological Chemistry.

[23]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[24]  A. Papi,et al.  Is there a difference between chronic airway inflammation in chronic severe asthma and chronic obstructive pulmonary disease? , 2005, Current opinion in allergy and clinical immunology.

[25]  W. MacNee,et al.  Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.

[26]  I. Adcock,et al.  Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages , 2004, The Journal of experimental medicine.

[27]  I. Adcock,et al.  Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  P. Paré,et al.  The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[29]  I. Adcock,et al.  Oxidative stress reduces histone deacetylase 2 activity and enhances IL-8 gene expression: role of tyrosine nitration. , 2004, Biochemical and biophysical research communications.

[30]  D. Schrijvers,et al.  Nucleofection as an efficient nonviral transfection method for human monocytic cells , 2003, Biotechnology Letters.

[31]  S. Bozinovski,et al.  Acquired somatic mutations in the molecular pathogenesis of COPD. , 2003, Trends in pharmacological sciences.

[32]  K. Varani,et al.  The FASEB Journal express article 10.1096/fj.02-0543fje. Published online December 3, 2002. Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation , 2022 .

[33]  I. Adcock,et al.  Increased p21(CIP1/WAF1) and B cell lymphoma leukemia-x(L) expression and reduced apoptosis in alveolar macrophages from smokers. , 2002, American journal of respiratory and critical care medicine.

[34]  W. Bailey,et al.  Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution , 2023, Medical science monitor : international medical journal of experimental and clinical research.

[35]  B. Cronstein,et al.  Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.

[36]  I. Adcock,et al.  p65-activated Histone Acetyltransferase Activity Is Repressed by Glucocorticoids , 2001, The Journal of Biological Chemistry.

[37]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[38]  S. Hotop,et al.  Peroxidative stress selectively down‐regulates the neuronal stress response activated under conditions of endoplasmic reticulum dysfunction , 2001, Journal of neurochemistry.

[39]  L. Fabbri,et al.  Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[40]  I. Adcock,et al.  Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12 , 2000, Molecular and Cellular Biology.

[41]  K. Klotz,et al.  [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors. , 2000, Molecular pharmacology.

[42]  P. Hiemstra,et al.  Monocyte chemoattractant protein 1, interleukin 8, and chronic airways inflammation in COPD , 2000, The Journal of pathology.

[43]  K. Klotz,et al.  [3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. , 2000 .

[44]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[45]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[46]  G. Dewald,et al.  Establishment of an immature mast cell line from a patient with mast cell leukemia. , 1988, Leukemia research.

[47]  D Rodbard,et al.  Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.

[48]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.